{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2510, 
        2524
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2997, 
        3006
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4891, 
        4914
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2383, 
        2410
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        540, 
        569
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4814, 
        4849
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2321, 
        2347
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2981, 
        2996
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2960, 
        2964
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2526, 
        2533
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2548, 
        2549
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2500, 
        2509
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2971, 
        2980
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4770, 
        4779
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3069, 
        3086
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170919125845||ORU^R01^ORU_R01|201709191258450001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-011578^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170822000000|||||||20170823000000|&Prostate, Radical Resection, Lymph Node, Biopsy|1770650145^^^^^^MD^^CMS^D^^^NPI||||||20170824000000|||F||||||C61^Malignant neoplasm of prostate^I10~D07.5^Carcinoma in situ of prostate^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient is \"\" identified by requisition and specimen container label. Received in formalin in a container labeled with the patient's name and \"prostate and pelvic lymph nodes\" is a radical prostatectomy specimen including attached seminal vesicles and vas deferens. Weight: 29 g. Size: 2.5 cm superior to inferior, 4 cm right to left and up to 3.8 cm anterior to posterior. Right seminal vesicle, attached: 2.8 x 1.5 x 0.7 cm. Left seminal vesicle, attached: 2.5 x 1 x 0.8 cm. Right vas deferens: Attached, 2 x 0.6 x 0.6 cm. Left vas deferens: Attached, 2.6 x 0.6 x 0.5 cm. Prostatic surface: Tan to red-brown cauterized around the bladder base. Inking code: Right half green, left half blue, anterior midline orange, posterior midline black. Sectioning: Apex and bladder base shaved off to be submitted. Remaining gland sectioned into 5 slices, numbered 1-5 sequentially from apex to base. The anterior half of the #5 slice is utilized for bladder base sections. Cut surface: Pink-tan to brown and focally cystic. Included in the container is a 3 x 1.5 x 1 cm aggregate of fatty tissue containing two 1.8 x 0.8 x 0.5 and 2.3 x 1 x 0.6 cm pink-tan and yellow mostly fat replaced candidate nodes. Sections comprising the entire prostate submitted. Cassette summary:  1A, right apex  1B, left apex  1C, right bladder base  1D, left bladder base  1E, right seminal vesicles, right vas deferens at margin  1F, left seminal vesicles, left vas deferens at margin  1G, right level 1  1H, right level 2  1I-1J, right level 3  1K-1L, right level 4  1M-1P, right level 5  1Q-1R, left level 1  1S-1T, left level 2  1U, left level 3  1V-1Y, left level 4  1Z-1AC, left level 5  1AD, one candidate node bisected  1AE-1AF, other candidate node bisected (DSP)\n\n\nPath report.site of origin\n\nProstate and pelvic lymph nodes\n\n\nPath report.final diagnosis\n\nProstate and pelvic lymph nodes (radical prostatectomy and pelvic lymph node biopsy):   Prostatic adenocarcinoma, Gleason's pattern 4+3=7 (70% pattern 4, grade group     3).   Tumor is bilateral occupying 30% of the gland.   The left seminal vesicle is positive.   Extraprostatic extension identified, left base posterior lateral.   Lymphovascular invasion is present.   Perineural invasion is present.   Margin of resection is positive in 10 mm of length, left base soft tissue adjacent to     left seminal vesicle.   Remaining gland demonstrates high grade prostatic intraepithelial neoplasia.   Two lymph nodes free of metastasis (0/2).   Stage pT3bpN0. CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 SPECIMEN  Procedure: Radical prostatectomy Prostate Size  Prostate Weight (g): 29grams  Prostate Size in Centimeters (cm): 4cm  Additional Dimension in Centimeters (cm): 3.8cm, 2.5cm TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Percentage of Pattern 4: 70%  Primary Gleason Pattern: Pattern 5  Secondary Gleason Pattern: Pattern 3  Total Gleason Score: 7  Grade Group: Grade group 3 Tumor Extent  Estimated percentage of prostate involved by tumor (specify %): 30%  Extraprostatic Extension (EPE): Present, focal  Location of Extraprostatic Extension: Left postero-lateral (neurovascular bundle)  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Present  Laterality: Left Accessory Findings  Treatment Effect: No known presurgical therapy  Lymphovascular Invasion: Present  Perineural Invasion: Present MARGINS  Margins: Involved by invasive carcinoma  Margin Limitations: Non-limited (>= 3 mm)  Linear Length of Positive Margin(s) in Millimeters (mm): 10mm  Focality: Unifocal  Location of Positive Margin(s): Left postero-lateral (neurovascular bundle)  Margin Positivity in Area of Extraprostatic Extension (EPE): Present  Gleason Pattern at Positive Margin(s): Pattern 4 or 5 LYMPH NODES  Number of Lymph Nodes Involved: None identified  Number of Lymph Nodes Examined: Specify number  Specify number: 2 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (pT)#: pT3b: Tumor invades seminal vesicle(s)  Regional Lymph Nodes (pN): pN0: No positive regional nodes ADDITIONAL FINDINGS  Additional Pathologic Findings: High-grade prostatic intraepithelial neoplasia (PIN)\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Malignant neoplasm of prostate (C61)\n\n\n"
}